EP 0656949 A1 19950614 - VACCINIA VIRUS B15R USED IN INTERLEUKIN B1-INVOLVING CONDITION.
Title (en)
VACCINIA VIRUS B15R USED IN INTERLEUKIN B1-INVOLVING CONDITION.
Title (de)
BEI INTERLEUKIN B1 HERVORGERUFENE ZUSTÄNDE BENUTZTER VACCINE VIRUS B15R.
Title (fr)
VIRUS DE LA VACCINE B15R UTILISE POUR TRAITER UN ETAT IMPLIQUANT L'INTERLEUKINE B1.
Publication
Application
Priority
- GB 9300460 W 19930305
- GB 9204780 A 19920305
Abstract (en)
[origin: WO9318153A1] This invention relates to proteins encoded by vaccinia virus and which function to interfere with the host's immune system. In particular, the invention provides for use of the nucleotide sequence designated herein as B15R or of a nucleotide sequence coding for an allele of, or functionally equivalent fragment, derivative or variant of the polypeptide encoded by the B15R nucleotide sequence in a process relating to the manufacture of a medicament for the treatment of a condition in which interleukin-1 beta is involved in the mediation of one or more symptoms associated with the condition. The invention also provides an anti-fever medicament which comprises a polypeptide which is encoded by the B15R gene product or an allele of, or functionally equivalent fragment, derivative or variant of that product.
IPC 1-7
IPC 8 full level
C07K 14/07 (2006.01); C07K 14/705 (2006.01); C12N 15/39 (2006.01); A61K 38/00 (2006.01)
CPC (source: EP)
C07K 14/005 (2013.01); C07K 14/70503 (2013.01); A61K 38/00 (2013.01); C12N 2710/24122 (2013.01)
Citation (search report)
See references of WO 9318153A1
Designated contracting state (EPC)
DE FR GB
DOCDB simple family (publication)
WO 9318153 A1 19930916; EP 0656949 A1 19950614; GB 9204780 D0 19920415
DOCDB simple family (application)
GB 9300460 W 19930305; EP 93905517 A 19930305; GB 9204780 A 19920305